Bertrand Ducrey

Investor

Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund

About

CEO of Debiopharm and Senior Vice-Chairman of the Life Science activities of Après-demain, overseeing drug development, formulation, manufacturing and digital health investment. He joined Debiopharm in 1995 and holds a PhD in Pharmaceutical Sciences from Lausanne University.

Colleagues at Debiopharm Innovation Fund

Angela Zubel

Chief Development Officer, Research & Development at Debiopharm Innovation Fund

Cedric Odje

Investment Associate at Debiopharm Innovation Fund

Frédéric Lévy

Chief Scientific Officer, Search & Evaluation and Scientific Innovation at Debiopharm Innovation Fund

Marc Cikes

Managing Director at Debiopharm Innovation Fund

Nicolas Favre

Chief Business Officer, Business Development & Commercial at Debiopharm Innovation Fund

Nicolas Stalder

Senior Investment Associate at Debiopharm Innovation Fund

Pierre Jullian

Chief Finance Officer, Finance, HR, IT & Administration at Debiopharm Innovation Fund

Sara Picó

Investor at Debiopharm Innovation Fund

Frequently asked questions

Who is Bertrand Ducrey?: CEO of Debiopharm and Senior Vice-Chairman of the Life Science activities of Après-demain, overseeing drug development, formulation, manufacturing and digital health investment. He joined Debiopharm in 1995 and holds a PhD in Pharmaceutical Sciences from Lausanne University.
Where does Bertrand Ducrey work?: Bertrand Ducrey is Chief Executive Officer, Debiopharm International & Senior Vice-Chairman, Debiopharm at Debiopharm Innovation Fund.